Universitätsmedizin Rostock

Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial (2015) Rollig C, Serve H, Huettmann A, Noppeney R, Mueller-Tidow C, Krug U, Baldus CD, et al. Journal article Overcoming the language barrier: UroEvidence translates Cochrane abstracts (2015) Schmidt S, Kunath F, Kranz J, Zengerling F, Draeger DL, Kroeger N, Krabbe LM, et al. Journal article Huge lipomatous tumor in the adductor muscle (2015) Zonnur S, Falkeis C, Ondang G, Weiner M, Maier H, Agaimy A Journal article Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)+ (2014) Von Minckwitz G, Loibl S, Untch M, Eidtmann H, Rezai M, Fasching P, Tesch H, et al. Journal article Deletions in the 3' part of the NFIX gene including a recurrent Alu-mediated deletion of exon 6 and 7 account for previously unexplained cases of Marshall-Smith syndrome (2014) Schanze D, Neubauer D, Cormier-Daire V, Delrue MA, Dieux-Coeslier A, Hasegawa T, Holmberg EE, et al. Journal article Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis (2014) Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, Bonnefoi H, et al. Journal article White paper: clinical studies in radiology (2014) Antoch G, Barkhausen J, Dueber C, Epsch R, Heindel W, Krombach G, Maintz D, et al. Journal article "UroEvidence" - Centre for knowledge translation of the DGU (German Society of Urology) : Summarizing, analysing and making current knowledge available (2014) Kranz J, Kunath F, Borgmann H, Dräger DL, Krabbe LM, Kröger N, Otto W, et al. Journal article Response and prognosis after neoadjuvant chemotherapy in 1,051 patients with infiltrating lobular breast carcinoma (2014) Loibl S, Volz C, Mau C, Blohmer JU, Costa SD, Eidtmann H, Fasching P, et al. Journal article Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40--GeparQuattro) (2014) Von Minckwitz G, Rezai M, Fasching P, Huober J, Tesch H, Bauerfeind I, Hilfrich J, et al. Journal article